BIONIC-I
LIVE

Serial Number

88876380

Owner

Ma, Joseph J.K.

Attorney

James R Menker

Filing Date

Apr 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BIONIC-I Trademark

Serial Number: 88876380 • Registration: 7797099

BIONIC-I is a trademark filed by Ma, Joseph J.K. on April 17, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Ma, Joseph J.K. (2 trademarks)

Willowdale, ON M2K1E6 , CA

Entity Type: 01

Trademark Details

Filing Date

April 17, 2020

Registration Date

May 13, 2025

Goods & Services

Provision of non-downloadable videos in the nature of augmented reality scenes and characters displayed on ocular implants and intraocular prosthesis lenses via a video-on-demand services for entertainment purposes

3D spectacles; contact lenses; corrective glasses; corrective spectacles; eyeglasses worn for sports training; eyeglasses for sports; eyeglass lenses; eyeglass frames; eye glasses; eyeglass cases; eyeglass chains and cords; eyeglass holders; eyeglass lanyards; eyeglass mountings; eyeglass nose pads; eyeglass temples; eyeglasses for children; eyeglasses for reading; eyewear pouches; protective face-shields for athletic use for protection against injury; field glasses; frames for eyeglasses; frames for monocles; frames for spectacles and sunglasses; goggles for sports; goggles for use in sport; lenses for microscopes; lenses for eyeglasses; lenses for spectacles; lenses for monocles; lenses for sunglasses; monocles; monocular frames; night vision goggles; ophthalmic eyeglasses; ophthalmic lenses; optical frames; optical glass; optical lenses; optical reflectors; optical spectacles; prescription eyeglasses; prescription goggles for sports; prescription spectacles; prescription sunglasses; progressive addition lenses for eyeglasses; progressive eyeglass lenses; protective eyeglass lenses; protective face-shields for protective helmets; safety goggles in the nature of protective goggles for animals; protective spectacles; reading eyeglasses; safety goggles; spectacle lenses; spectacle temples; spectacles; spectacles, spectacle frames and spectacle cases; sports eyewear; sports goggles; spyglasses; sunglasses; theatre glasses; unmounted spectacle frames; varifocal eyeglass lenses; varifocal eyeglasses; varifocal spectacle lenses; downloadable computer software for recording and tracking sensory and visual data from eye movements for medical purposes, preventative and predictive health, and general health and well-being; downloadable computer software for providing, transmitting and reproducing eye movement and visual sensory data through electrical relays for medical purposes, preventative and predictive health, and general health and well-being; downloadable computer software for recording, manipulating, processing and enhancing images, sound and video for use in visual prosthesis for medical purposes, preventative and predictive health, and general health and well-being; downloadable computer software for recording, manipulating, processing and enhancing images to improve the visibility of objects for medical purposes, preventative and predictive health, and general health and well-being

Ocular medications; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system, namely, ocular motility; eyedrops; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of infectious diseases, namely, eye infections; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for use in ophthalmology; pharmaceutical products for ophthalmological use

Ophthalmology services; medical services in the nature of medical consultancy relating to vision loss; medical services in the nature of medical diagnostic services; medical services in the nature of professional consultancy in the field of medical technology, medical surgery and ophthalmology; eyeglass fitting; fitting of eyeglasses; fitting of prosthetic devices; laser vision correction services; laser vision surgery services; medical services in the nature of medical care and analysis services relating to patient treatment; medical clinic services; medical clinics; medical diagnostic services; optician services; optometry services

Apparatus used in implementing diagnosis tests designed to detect ocular disease; intraocular prosthesis lenses for surgical implantation; artificial eyes; artificial lens for implantation in the eye; ocular implants made of artificial materials; ocular speculums; electronic medical devices implanted in the eye to help restore vision; eye testing machines; intraocular lenses; intraocular prosthetic lenses for surgical implantation; lasers for eye surgery

Providing temporary use of non-downloadable computer software for recording and tracking sensory and visual data from eye movements for medical purposes, preventative and predictive health, and general health and well-being; providing temporary use of non-downloadable computer software for providing, transmitting and reproducing eye movement and visual sensory data through electrical relays for medical purposes, preventative and predictive health, and general health and well-being; providing temporary use of non-downloadable computer software for recording, manipulating, processing and enhancing images, sound and video for use in visual prosthesis for medical purposes, preventative and predictive health, and general health and wellbeing; providing temporary use of non-downloadable computer software for recording, manipulating, processing and enhancing images to improve the visibility of objects for medical purposes, preventative and predictive health, and general health and well-being

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 13, 2025 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
May 13, 2025 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Apr 11, 2025 CNTA
EXAMINER'S AMENDMENT ENTERED
Apr 11, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 11, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 11, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 11, 2025 CNEA
DIVISIONAL PROCESSING COMPLETE
Apr 10, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 27, 2025 AITU
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 18, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 18, 2025 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 9, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 9, 2024 XELR
DIVISIONAL REQUEST RECEIVED
Aug 21, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Aug 21, 2024 ERTD
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 17, 2024 GNFN
FINAL REFUSAL E-MAILED
Aug 17, 2024 GNFR
FINAL REFUSAL WRITTEN
Aug 17, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 5, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 5, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 5, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 5, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 5, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 18, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 5, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 5, 2023 GNSL
SUSPENSION LETTER WRITTEN
Dec 5, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 18, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 23, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 23, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 23, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 5, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 23, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 23, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jan 23, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 6, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 15, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 15, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 15, 2022 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 22, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 1, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 1, 2021 GNSL
SUSPENSION LETTER WRITTEN
Dec 1, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 9, 2021 CRFA
ASSIGNED TO LIE
Nov 9, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 4, 2021 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 4, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 27, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 27, 2020 GNSL
SUSPENSION LETTER WRITTEN
Oct 27, 2020 CNSL
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 16, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 16, 2020 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 16, 2020 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 12, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 11, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 11, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 10, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 10, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 10, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 9, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2020 NWOS
NEW APPLICATION ENTERED
Apr 21, 2020 NWAP